We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0NJP market cap is 1.02B. The company's latest EPS is EUR and P/E is N/A.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 913.2M | 983.71M | 1.12B | 1.46B | 1.53B |
| Operating Income | 106.1M | 144.05M | 134.99M | 192.83M | 238M |
| Net Income | 49.34M | 103.05M | 89.55M | 133.69M | 145.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 1.25B | 1.41B | 1.44B | 1.72B | 1.94B |
| Total Liabilities | 674.5M | 751.43M | 723M | 855.95M | 965.54M |
| Total Equity | 579.92M | 662.85M | 721.45M | 862.63M | 975.13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 186.39M | 199.35M | 192.56M | 214.92M | 270.06M |
| Investing | -212.34M | -127.75M | -229.52M | -252.3M | -246.7M |
| Financing | 66.72M | 27.38M | -93.53M | 30.35M | 52.42M |
| Market Cap | 1.02B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 90.7M |
| Average Volume (1 week) | 8.69k |
| Average Volume (1 Month) | 7.66k |
| 52 Week Change | 0.00% |
| 52 Week High | 11.23 |
| 52 Week Low | 11.23 |
| Spread (Intraday) | 0.54 (4.7%) |
| Company Name | Sol Spa |
| Address |
via borgazzi 27 monza, monza and brianza 20900 |
| Website | https://www.sol.it |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
